Your browser doesn't support javascript.
loading
Global surveillance of antimicrobial resistance in food animals using priority drugs maps.
Zhao, Cheng; Wang, Yu; Mulchandani, Ranya; Van Boeckel, Thomas P.
Afiliação
  • Zhao C; Health Geography and Policy Group, ETH Zürich, Zürich, Switzerland.
  • Wang Y; Health Geography and Policy Group, ETH Zürich, Zürich, Switzerland.
  • Mulchandani R; Health Geography and Policy Group, ETH Zürich, Zürich, Switzerland.
  • Van Boeckel TP; Health Geography and Policy Group, ETH Zürich, Zürich, Switzerland. thomas.van.boeckel@gmail.com.
Nat Commun ; 15(1): 763, 2024 Jan 26.
Article em En | MEDLINE | ID: mdl-38278814
ABSTRACT
Antimicrobial resistance (AMR) in food animals is a growing threat to animal health and potentially to human health. In resource-limited settings, allocating resources to address AMR can be guided with maps. Here, we mapped AMR prevalence in 7 antimicrobials in Escherichia coli and nontyphoidal Salmonella species across low- and middle-income countries (LIMCs), using 1088 point-prevalence surveys in combination with a geospatial model. Hotspots of AMR were predicted in China, India, Brazil, Chile, and part of central Asia and southeastern Africa. The highest resistance prevalence was for tetracycline (59% for E. coli and 54% for nontyphoidal Salmonella, average across LMICs) and lowest for cefotaxime (33% and 19%). We also identified the antimicrobial with the highest probability of resistance exceeding critical levels (50%) in the future (1.7-12.4 years) for each 10 × 10 km pixel on the map. In Africa and South America, 78% locations were associated with penicillins or tetracyclines crossing 50% resistance in the future. In contrast, in Asia, 77% locations were associated with penicillins or sulphonamides. Our maps highlight diverging geographic trends of AMR prevalence across antimicrobial classes, and can be used to target AMR surveillance in AMR hotspots for priority antimicrobial classes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Animals / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Animals / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça